Results 1 to 10 of about 5,666 (166)
Trichloroethylene increases pulmonary endothelial permeability: implication for pulmonary veno-occlusive disease [PDF]
Pulmonary Circulation, 2020 Trichloroethylene exposure is a major risk factor for pulmonary veno-occlusive disease. We demonstrated that trichloroethylene alters the endothelial barrier integrity, at least in part, through vascular endothelial (VE)-Cadherin internalisation, and ...
Julien Caliez +14 more
doaj +4 more sources
Pulmonary veno‐occlusive disease with vanished pulmonary consolidation [PDF]
Respirology Case Reports, 2023 Key message Pulmonary veno‐occlusive disease (PVOD) is an extremely rare cause of pulmonary hypertension. Previously reported computed tomography (CT) findings of PVOD included centrilobular ground‐glass opacities, a mosaic pattern, and septal lines ...
Kei Yamasaki +6 more
doaj +3 more sources
Pulmonary Veno-Occlusive Disease [PDF]
Veterinary Pathology, 2016 Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary hypertension (PH) characterised by preferential remodelling of the pulmonary venules. In the current PH classification, PVOD and pulmonary capillary haemangiomatosis (PCH) are considered
S French, S Jennings, S L Priestnall
exaly +6 more sources
Mitomycin induced pulmonary veno-occlusive disease [PDF]
Respiratory Medicine Case Reports, 2021 Pulmonary veno-occlusive disease (PVOD) is a rare but devastating cause of pulmonary hypertension (PH) characterized by preferential remodeling of the pulmonary venules.Mitomycin-C (MMC) is an alkylating agent commonly used in chemotherapy with ...
Afua Kunadu +5 more
doaj +3 more sources
Pulmonary Veno-Occlusive Disease after Autologous Stem Cell Transplantation [PDF]
Case Reports in Oncology, 2023 Pulmonary veno-occlusive disease (PVOD) is an extremely rare condition in oncology practice. Although PVOD is clinically similar to pulmonary arterial hypertension, the conditions differ in terms of pathophysiology, management, and prognosis. This report
Takashi Hamada +14 more
doaj +3 more sources
When you hear hoofbeats, think zebras – pulmonary veno‐occlusive disease: A case report [PDF]
Pulmonary Circulation, 2022 Pulmonary veno‐occlusive disease (PVOD) is a rare disease. It may be idiopathic or associated, in particular, with connective tissue disease, or it may develop after radiation exposure; in heritable forms of PVOD, the inheritance is autosomal recessive ...
Laura Scelsi +9 more
doaj +3 more sources
Pulmonary veno-occlusive disease: illustrative cases and literature review [PDF]
European Respiratory ReviewPulmonary veno-occlusive disease (PVOD), also known as “pulmonary arterial hypertension (PAH) with overt features of venous/capillary involvement”, is a rare cause of PAH characterised by substantial small pulmonary vein and capillary involvement ...
Benoit Lechartier +7 more
doaj +3 more sources
Efficacy and safety of oral pulmonary vasodilators in pulmonary veno‐occlusive disease [PDF]
Pulmonary Circulation, 2022 Pulmonary veno‐occlusive disease (PVOD) or pulmonary capillary hemangiomatosis (PCH) is a rare subtype of pulmonary hypertension with dismal prognosis.
Junichi Nakamura +12 more
doaj +3 more sources
Anti-synthetase syndrome-associated pulmonary veno-occlusive disease [PDF]
Pulmonary Circulation, 2020 Pulmonary arterial hypertension has been reported with a prevalence of 7.9% in patients with anti-synthetase syndrome; however, anti-synthetase syndrome associated with pulmonary veno-occlusive disease (PVOD) has never before been described in the ...
Dana Kay +5 more
doaj +3 more sources
Pulmonary veno-occlusive disease in Sjogren's syndrome: a case report [PDF]
BMC Pulmonary Medicine, 2023 Background Pulmonary arterial hypertension (PAH) associated with connective tissue disease (CTD) belongs to Group 1 pulmonary hypertension. Pulmonary veno-occlusive disease (PVOD), which is characterized by venous system aberrations, has been previously ...
Xiaofang Zeng +8 more
doaj +3 more sources